Alerts will be sent to your verified email
Verify EmailDIVISLAB
|
Divi's Lab
|
Laurus Labs
|
Neuland Laboratories
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
R&D as a % of Total Sales
|
0.86 % | 4.6 % | 4.15 % |
|
Financials
|
|||
|
5 yr Average ROE
|
17.46 % | 18.77 % | 14.95 % |
|
5yr average Equity Multiplier
|
1.2 | 2.06 | 1.56 |
|
5yr Average Asset Turnover Ratio
|
0.55 | 0.71 | 0.74 |
|
5yr Avg Net Profit Margin
|
25.76 % | 11.95 % | 13.18 % |
|
Price to Book
|
11.15 | 11.53 | 13.39 |
|
P/E
|
69.15 | 80.98 | 90.31 |
|
5yr Avg Cash Conversion Cycle
|
134.41 Days | 91.73 Days | 38.21 Days |
|
Inventory Days
|
121.85 Days | 114.71 Days | 87.5 Days |
|
Days Receivable
|
94.81 Days | 120.6 Days | 85.17 Days |
|
Days Payable
|
94.55 Days | 145.16 Days | 118.14 Days |
|
5yr Average Interest Coverage Ratio
|
1162.71 | 8.98 | 20.78 |
|
5yr Avg ROCE
|
21.97 % | 22.73 % | 17.63 % |
|
5yr Avg Operating Profit Margin
|
34.94 % | 24.36 % | 21.01 % |
|
5 yr average Debt to Equity
|
0.0 | 0.56 | 0.15 |
|
5yr CAGR Net Profit
|
2.0 % | -18.29 % | 26.4 % |
|
5yr Average Return on Assets
|
14.47 % | 8.99 % | 9.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
51.89 % | 27.59 % | 32.64 % |
|
Share Pledged by Promoters
|
0.0 | 2.69 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.05 % | 0.32 % | -3.58 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.37 % | 3.03 % | 8.99 % |
|
Divi's Lab
|
Laurus Labs
|
Neuland Laboratories
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|
|
Asset Break-Up
|
Asset Break-Up
|
-
|
Asset Break-Up
|